ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Addex to lead mGlu7 NAM-focused PTSD consortium pharmaceutical-technology
July 10, 2019Swiss-headquartered Addex Therapeutics has announced it will lead a consortium to develop small molecule negative allosteric modulators (NAMs) indicated to reduce fear memory in post-traumatic stress disorder (PTSD).
Pharma Sources Insight January 2025
